University of Glasgow Enhances Biomedical Engineering Capabilities With Purchase of a NanoInk, Inc. DPN 5000 System
Published: Oct 16, 2012
CHICAGO, IL--(Marketwire - October 16, 2012) -
University of Glasgow?s Advanced Medical Diagnostics research group
The Advanced Medical Diagnostics research group, led by Professor Jonathan Cooper, was established over 20 years ago. It has a strong track record in many aspects of bioengineering, especially those associated with advanced biomedical diagnostics, biosensors, cell engineering, lab-on-a-chip and bio-nanotechnology.
The DPN 5000 System is a full-featured tip-based lithography platform capable of multi-component deposition of a wide range of materials in sub-micron sized features. Its intuitive user interface enables the deposition of complex nanopatterns by precisely controlling tip movements during the writing process. DPN 5000 System users can easily design, create, and analyze nano and microstructures on a variety of substrates.
"With the acquisition of NanoInk's DPN 5000 system, we saw the opportunity to expand our already wide-ranging research capabilities with a state-of-the-art nanofabrication instrument," said Jonathan Cooper, Professor of Bioelectronics and Bioengineering, Dean of Graduate Studies. "The NanoInk platform will allow us to explore novel sensors and systems based around the combination of our micro and nano-engineered devices with complex molecular nanopatterns."
"We are delighted that the Biomedical Engineering Research Division at the University of Glasgow selected our DPN 5000 System," said Robert Marchmont, General Manager of NanoInk's NanoFabrication Systems Division, Europe, the Middle East and Africa. "With the DPN 5000 system, Professor Cooper and his team will be able to pioneer new micro and nano-engineered devices in support of their mission, which is the development of advanced diagnostics."
More information about the University of Glasgow's Advanced Medical Diagnostics research group is available at: www.gla.ac.uk/schools/engineering/research/divisions/biomedical/advancedmedicaldiagnosticsloac/.
NanoInk's NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable platform. More information is available at: www.nanoink.net/divisions.html#NanoFabrication. You can also follow NanoInk on Twitter at www.twitter.com/NanoInk, Facebook at www.facebook.com/nanoink.net, Google+ at www.gplus.to/nanoink, YouTube at www.youtube.com/user/nanoINKtv, and LinkedIn at www.linkedin.com/groups/Nano-Micro-Lithography-3791030/about?trk=anet_ug_grppro.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has several divisions including the NanoFabrication Systems Division, the Nano BioDiscovery Division, the NanoProfessor™ Division and the NanoGuardian™ Division. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.
NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN, and NanoProfessor are registered trademarks of NanoInk, Inc.
Dresner Corporate Services
Dresner Corporate Services